AROCELL AB
AROCELL AB
Share · SE0003883990 · A12CNW (XSTO)
Overview
No Price
n/a
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Share Float & Liquidity
Free Float 60,96 %
Shares Float 140,42 M
Shares Outstanding 230,36 M
Company Profile for AROCELL AB Share
AroCell AB (publ), a vitro diagnostics company, focuses on monitoring of hematological malignancies, breast cancer, and other solid tumors. The company develops, manufactures, and sells AroCell TK 210 ELISA, an immunoassay kit for the determination of Thymidine Kinase 1 in human blood. It also offers TUBEX TF, a bacteriological rapid test for diagnosis of typhoid fever. The company was formerly known as Xi Bao Research AB and changed its name to AroCell AB (publ) in 2006. AroCell AB (publ) was incorporated in 2000 and is based in Uppsala, Sweden.

Company Data

Name AROCELL AB
Company AroCell AB (publ)
Website https://www.arocell.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
WKN A12CNW
ISIN SE0003883990
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Anders Hultman
Market Capitalization 132 Mio
Country Sweden
Currency SEK
Employees 0,0 T
Address Uppsala Business Park, 754 50 Uppsala
IPO Date 2011-05-25

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB AROC.ST
Frankfurt 80R.F
More Shares
Investors who hold AROCELL AB also have the following shares in their portfolio:
BAYER US FIN. 14/21 REGS
BAYER US FIN. 14/21 REGS Bond
PERPETUUM VITA BASIS R
PERPETUUM VITA BASIS R Fund
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025